Please assess the completion status of the following clinical trial:

Trial Title: Exercise in Patients With a Total Coronary Occlusion

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Single vessel disease with a chronic total occlusion of the right coronary artery, left anterior descending artery, or left circumflex artery, as identified on coronary angiography performed within the preceding 24 months.~* Willingness to undertake maximal cardiopulmonary exercise test~* Resting systolic blood pressure \<180mmHg~* Resting Diastolic blood pressure \<100mmHg~* Aged \>18yrs~* Normal resting left ventricular function~* Able to provide written informed consent~Exclusion Criteria:~* Significant proximal left main stem stenosis.~* Multi-vessel disease (defined as a diameter stenosis of \>50% in another major epicardial coronary vessel)~* Absence of exercise-induced ischaemia evidenced by O2/HR or, ΔVO2/ ΔWR inflection at visit 1 and 2~* O2/HR inflection or, ΔVO2/ ΔWR inflection at a respiratory exchange ratio \>1.05~* Change in cardiac medications within previous two weeks~* Unstable angina~* Myocardial infarction within the preceding 6 weeks~* Canadian classification system for angina class IV~* Chronic heart failure~* Significant valvular pathology~* Resting ejection fraction \<40%~* Severe orthopaedic limitations~* Past history of Complex arrhythmias~* Atrial fibrillation~* Severe COPD~* Symptoms of intermittent claudication~* Unable to provide written informed consent~* Previous permanent pacemaker implant~* Use of short-term GTN within 30 minutes of exercise testing

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- CTO Exerciser (Type: EXPERIMENTAL): 2x Symptom limited cardiopulmonary exercise tests~1x Sub-maximal cardiopulmonary exercise test (20 minutes)

Based on this trial design, predict the completion outcome and termination type (if applicable).